As of 2025-03-17, the Relative Valuation of Eupraxia Pharmaceuticals Inc (EPRX.TO) is 5.96 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 5.97 CAD, the upside of Eupraxia Pharmaceuticals Inc based on Relative Valuation is -0.1%.
The range of the Relative Valuation is 5.96 - 5.96 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -4.6x - -4.6x | -4.6x |
| Fair Price | 5.96 - 5.96 | 5.96 |
| Upside | -0.1% - -0.1% | -0.1% |
| Date | P/E |
| 2025-03-04 | -4.01 |
| 2025-03-03 | -4.27 |
| 2025-02-28 | -4.40 |
| 2025-02-27 | -4.44 |
| 2025-02-26 | -4.64 |
| 2025-02-25 | -4.55 |
| 2025-02-24 | -4.11 |
| 2025-02-21 | -4.07 |
| 2025-02-20 | -3.90 |
| 2025-02-19 | -3.62 |
| 2025-02-18 | -3.63 |
| 2025-02-14 | -3.49 |
| 2025-02-13 | -3.53 |
| 2025-02-12 | -3.49 |
| 2025-02-11 | -3.47 |
| 2025-02-10 | -3.49 |
| 2025-02-07 | -3.55 |
| 2025-02-06 | -3.46 |
| 2025-02-05 | -3.39 |
| 2025-02-04 | -3.43 |
| 2025-02-03 | -3.39 |
| 2025-01-31 | -3.43 |
| 2025-01-30 | -3.36 |
| 2025-01-29 | -3.28 |
| 2025-01-28 | -3.28 |
| 2025-01-27 | -3.34 |
| 2025-01-24 | -3.36 |
| 2025-01-23 | -3.32 |
| 2025-01-22 | -3.43 |
| 2025-01-21 | -3.54 |
| 2025-01-20 | -3.58 |
| 2025-01-17 | -3.57 |
| 2025-01-16 | -3.38 |
| 2025-01-15 | -3.42 |
| 2025-01-14 | -3.35 |
| 2025-01-13 | -3.32 |
| 2025-01-10 | -3.33 |
| 2025-01-09 | -3.34 |
| 2025-01-08 | -3.32 |
| 2025-01-07 | -3.27 |
| 2025-01-06 | -3.27 |
| 2025-01-03 | -3.39 |
| 2025-01-02 | -3.44 |
| 2024-12-31 | -3.48 |
| 2024-12-30 | -3.39 |
| 2024-12-27 | -3.46 |
| 2024-12-24 | -3.46 |
| 2024-12-23 | -3.39 |
| 2024-12-20 | -3.34 |
| 2024-12-19 | -3.39 |